Today: 9 June 2026
Browse Category

NASDAQ:SPRE 4 January 2026 - 23 February 2026

Spyre Therapeutics stock dips premarket after Friday surge as $500 million shelf hangs over shares

Spyre Therapeutics stock dips premarket after Friday surge as $500 million shelf hangs over shares

Spyre Therapeutics shares dropped 4.2% to $41.38 in premarket trading Monday after a 14.3% surge Friday. The move follows Thursday’s filing of a $500 million shelf registration, raising dilution concerns. Investors are watching for initial Phase 2 ulcerative colitis data, expected in the second quarter of 2026. Spyre ended 2025 with $757 million in cash and marketable securities.
23 February 2026
·
Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Spyre Therapeutics shares dropped 6.6% to $30.58 on Friday, closing near session lows after about 889,000 shares traded. The move followed comments from Philadelphia Fed President Anna Paulson signaling rate cuts may be delayed. Spyre remains below its 52-week high of $34.49, with traders eyeing whether the stock can hold above $30 at Monday’s open. No significant company news has been released since the last quarterly update.
4 January 2026
·

Stock Market Today

  • Euronext Updates AEX and AMX Indices: Adds Aalberts and CSG
    June 9, 2026, 1:23 PM EDT. Euronext, the Pan-European stock exchange, announced changes to the Netherlands' AEX and AMX indices, effective June 22. The AEX index, representing the top Dutch stocks, will include Aalberts, reflecting its market capitalization and liquidity. Meanwhile, the AMX, which tracks mid-cap Dutch companies, will add CSG. These periodic reviews ensure indices accurately represent the evolving Dutch market landscape, impacting fund trackers and investor portfolios tied to these benchmarks.

Latest articles

Archer Aviation Drops After Cathie Wood Selloff; What Traders Are Tracking

Archer Aviation Drops After Cathie Wood Selloff; What Traders Are Tracking

9 June 2026
Archer Aviation plunged 9.1% to $5.21 after ARK Invest dumped over 2.2 million shares worth $12.7 million, intensifying pressure as investors fled speculative growth stocks; with FAA certification still pending and heavy cash burn, Archer’s stock remains vulnerable to further selloffs if milestones slip.
Aurora Shares Fall as Uber Pulls Back, Tech Stocks Struggle

Aurora Shares Fall as Uber Pulls Back, Tech Stocks Struggle

9 June 2026
Aurora shares dropped 3.5% to $6.04 as tech and autonomous-driving stocks slid, with Uber’s recent block sale of 67.5 million shares at $7.10 still weighing on sentiment; Aurora reported a Q1 net loss of $223 million on $1 million revenue, expects continued losses, and may need to raise more capital to support its commercial ramp.
United Natural Foods Shares Fall After Revenue Miss

United Natural Foods Shares Fall After Revenue Miss

9 June 2026
United Natural Foods plunged 12.4% to $45.25 after quarterly revenue missed estimates, falling 4.2% to $7.72 billion versus the $7.80 billion consensus, with full-year guidance also slightly below Wall Street expectations, despite matching adjusted EPS and improved profit and debt metrics.
BlackBerry Shares Stall After QNX Push

BlackBerry Shares Slip Ahead of Results — What’s Moving BB Today

9 June 2026
BlackBerry’s U.S. shares plunged 8.5% to $8.50 as investors braced for the June 25 earnings report, with focus on whether the company can meet its bullish Q1 revenue forecast of $132–$140 million, well above analysts’ estimates, after QNX’s 20% revenue jump and $950 million royalty backlog last quarter.
Chip Selloff Trips Up Wall Street’s AI Rally

Chip Selloff Trips Up Wall Street’s AI Rally

9 June 2026
Nasdaq and S&P 500 tumbled midday, erasing early chip-stock gains as tech shares slid; Philadelphia Semiconductor Index dropped 2% after jumping 3%, with Broadcom, Micron, and Nvidia under pressure. Investors await key inflation data Wednesday and SpaceX’s massive IPO, both seen as catalysts for further volatility amid concerns that high valuations in AI and tech could face profit-taking if rate fears persist.
Go toTop